This protocol is judged by an institutional evaluate board, an independent group that assessments any medical trials involving individuals. If a analyze entails a Agenda I drug, as soon as the board approves the protocol as ethical, the researchers need to make an application for an investigational new drug (IND) number in the FDA.The good news is